Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients (MANON 02)

This study has been completed.
Sponsor:
Information provided by:
Objectif Recherche Vaccins SIDA
ClinicalTrials.gov Identifier:
NCT00219362
First received: September 16, 2005
Last updated: November 24, 2009
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)
Publications: